BlackRock, Inc. filed an amended beneficial ownership statement with the SEC on October 27, 2026, disclosing a 7.4% stake in Harrow, Inc., a specialty pharmaceutical company headquartered in Nashville, Tennessee, as of the event date of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: BlackRock, Inc. reported beneficial ownership of 2,757,783 shares of Harrow, Inc. common stock (CUSIP 415858109), representing 7.4% of the class.
  • Sole voting power: BlackRock reported sole voting power over 2,692,848 shares, with no shared voting power.
  • Sole dispositive power: BlackRock reported sole dispositive power over all 2,757,783 shares, with no shared dispositive power.
  • Event date: The triggering event date for this filing is September 30, 2026.
  • Filing signed: Spencer Fleming, Managing Director at BlackRock, Inc., signed the statement on October 27, 2026.
  • No single third-party interest above 5%: According to the filing, no one person's interest in Harrow, Inc. common stock is more than five percent of total outstanding common shares.

BlackRock's Amended Position in Harrow, Inc. Common Stock

BlackRock, Inc., a Delaware-incorporated parent holding company headquartered at 50 Hudson Yards, New York, NY 10001, filed this amended statement disclosing its beneficial ownership of Harrow, Inc. common stock. Harrow, Inc. is a specialty pharmaceutical issuer with principal executive offices located at 1A Burton Hills Blvd., Suite 200, Nashville, TN 37215. The filing covers shares held across certain business units of BlackRock and its subsidiaries and affiliates, collectively referred to in the document as the "Reporting Business Units."

According to the filing, the ownership reported "reflects the securities beneficially owned, or deemed to be beneficially owned, by certain business units (collectively, the 'Reporting Business Units') of BlackRock, Inc. and its subsidiaries and affiliates." The filing further notes that it "does not include securities, if any, beneficially owned by other business units whose beneficial ownership of securities are disaggregated from that of the Reporting Business Units." The identity and classification of the relevant subsidiary that acquired the securities is set out in Exhibit 99 attached to the filing.

BlackRock certified in the filing that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer." The filing is designated as Amendment No. 1, indicating that BlackRock had previously filed a Schedule 13G with respect to Harrow, Inc. common stock.

What Was Disclosed

BlackRock, Inc. disclosed beneficial ownership of 2,757,783 shares of Harrow, Inc. common stock, equal to 7.4% of the class, with sole voting power over 2,692,848 shares and sole dispositive power over all 2,757,783 shares, as of September 30, 2026.